Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Infect Dis ; 180(3): 780-90, 1999 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-10438367

RESUMO

A spectrum of clinical and epidemiologic studies implicate infectious agents, including Chlamydia pneumoniae, in the pathogenesis of atherosclerosis. The complexity of atherosclerotic disease necessitates examining the role of infection in the context of defined risk factors, such as high levels of native low-density lipoprotein (LDL). Although native LDL does not have atherogenic properties, cellular oxidation of LDL alters the lipoprotein into a highly atherogenic form. In this report, C. pneumoniae and chlamydial hsp60, an inflammatory antigen that was recently localized to atheromas, were found to induce cellular oxidation of LDL. These data provide initial evidence that an infectious agent can render LDL atherogenic and suggest a mechanism whereby C. pneumoniae may promote atheroma development.


Assuntos
Chlamydophila pneumoniae/metabolismo , Lipoproteínas LDL/sangue , Lipoproteínas LDL/metabolismo , Arteriosclerose/etiologia , Células Cultivadas , Chaperonina 60/metabolismo , Fibroblastos/citologia , Fibroblastos/metabolismo , Humanos , Masculino , Malondialdeído/análise , Monócitos/efeitos dos fármacos , Monócitos/microbiologia , Monócitos/fisiologia , Fatores de Risco , Pele/citologia , Pele/metabolismo , Substâncias Reativas com Ácido Tiobarbitúrico/análise , Vitamina E/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA